Leadership Overview
OPKO Health has 5 executives leading key functions including corporate strategy, renal therapeutics, financial operations, marketing, and technical innovation.
Committed to advancing patient care through integrated diagnostics and pharmaceutical solutions, OPKO Health drives global health outcomes by bridging the gap between complex disease discovery and commercialized medical testing services.
Committed to advancing patient care through integrated diagnostics and pharmaceutical solutions, OPKO Health drives global health outcomes by bridging the gap between complex disease discovery and commercialized medical testing services.
Leadership Roles at OPKO Health
Phil Frost - Chief Executive Officer & Chairman
Phil Frost, the Chief Executive Officer & Chairman at OPKO Health, directs the overarching corporate strategy and long-term vision for this diversified healthcare enterprise. Frost oversees the integration of pharmaceutical development with large-scale diagnostic testing services to ensure market competitiveness across the United States and international territories. By aligning the board of directors with the operational goals of the diagnostics and pharmaceutical segments, the Chief Executive Officer & Chairman maintains a focus on high-growth therapeutic areas and molecular testing innovation. Phil Frost manages the expansion of the company's biotechnology pipeline, specifically targeting oncology and infectious disease advancements. Through rigorous oversight of capital allocation and strategic partnerships, the Chief Executive Officer & Chairman secures the company's position as a leader in the healthcare sector. This leadership approach fosters a culture of scientific excellence and operational efficiency, ultimately driving value for shareholders and patients alike.
Charles Bishop - Chief Executive Officer, OPKO Renal
Charles Bishop, the Chief Executive Officer, OPKO Renal at OPKO Health, directs the specialized development and commercialization of treatments within the endocrinology and renal therapeutic sectors. Bishop oversees the clinical progression of pharmaceutical assets designed to address chronic kidney disease and related metabolic conditions. By coordinating with research teams, the Chief Executive Officer, OPKO Renal ensures that therapeutic candidates meet rigorous regulatory standards while preparing for broad market entry. Charles Bishop manages the strategic deployment of resources to maximize the impact of renal-focused medicines across global markets. This role involves constant collaboration with the broader executive team to align renal product development with the company's overall diagnostic capabilities. Through the application of deep scientific expertise, the Chief Executive Officer, OPKO Renal optimizes the commercial trajectory of the company's pharmaceutical portfolio, ensuring that innovative treatments reach patients requiring specialized care for complex endocrine and renal health challenges.
Adam Logal - Chief Financial Officer & Senior VP
Adam Logal, the Chief Financial Officer & Senior VP at OPKO Health, directs the financial architecture and fiscal planning for the entire organization. Logal oversees capital structure, investor relations, and the financial reporting processes that support the company's dual-segment operations in pharmaceuticals and diagnostics. By managing the balance sheet and liquidity, the Chief Financial Officer & Senior VP ensures the availability of resources for ongoing research and development initiatives. Adam Logal coordinates with the board and executive leadership to evaluate potential acquisitions and strategic investments that align with the company's long-term growth objectives. This role involves maintaining rigorous financial controls across all international and domestic operations to ensure compliance and transparency. Through the optimization of operational budgets and the management of financial risk, the Chief Financial Officer & Senior VP provides the stability necessary for the company to continue its mission of delivering advanced medical testing and therapeutic solutions to the global healthcare market.
Adam Ali - Chief Marketing Officer & Team Leader (US)
Adam Ali, the Chief Marketing Officer & Team Leader (US) at OPKO Health, directs the commercial strategy and market positioning for diagnostic testing services and pharmaceutical products within the United States. Ali oversees the development of outreach programs that connect clinical reference laboratory services with healthcare providers and patients. By analyzing market trends in molecular diagnostics, genetics, and women's health, the Chief Marketing Officer & Team Leader (US) crafts campaigns that highlight the company's unique testing capabilities. Adam Ali manages the sales and marketing teams to ensure consistent growth in diagnostic volume and pharmaceutical adoption. This role involves close collaboration with operational leaders to align service delivery with customer needs across the domestic market. Through the implementation of data-driven marketing strategies, the Chief Marketing Officer & Team Leader (US) expands the company's footprint, ensuring that diagnostic testing services and therapeutic offerings remain at the forefront of the competitive healthcare landscape.
Jane Hsiao - Chief Technical Officer & Vice Chairman
Jane Hsiao, the Chief Technical Officer & Vice Chairman at OPKO Health, directs the scientific innovation and technical development of the company's diagnostic and pharmaceutical platforms. Hsiao oversees the discovery and advancement of multispecific antibody therapies and the refinement of clinical laboratory testing methodologies. By leading the technical teams, the Chief Technical Officer & Vice Chairman ensures that the company maintains a competitive edge in molecular diagnostics, genetics, and anatomical pathology. Jane Hsiao manages the integration of new technologies into the existing diagnostic infrastructure to improve testing accuracy and efficiency. This role involves providing technical guidance to the board and collaborating with other executives to translate scientific breakthroughs into commercialized medical solutions. Through the oversight of research and development processes, the Chief Technical Officer & Vice Chairman drives the company's ability to address serious diseases, ensuring that technical capabilities remain aligned with the evolving needs of the global healthcare industry.
Explore Leadership Teams in Healthcare Services
Labcorp Holdings Inc. operates as a laboratory services company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Diagnostics Laboratories (Dx) and Biopharma Laboratory Services (BLS). The company offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, PAP tests, hemoglobin A1C and vitamin D, prostate-specific antigens, tests for sexually transmitted diseases, hepatitis C tests, microbiology cultures and procedures, and alcohol and other substance-abuse tests. It also provides specialty testing services comprising gene-based and esoteric testing; advanced tests target specific diseases; services related to anatomic pathology/oncology, cardiovascular disease, coagulation, diagnostic genetics, endocrinology, infectious disease, women's health, pharmacogenetics, parentage and donor testing, occupational testing services, medical drug monitoring services, chronic disease programs, and kidney stone prevention tests; and health and wellness services to employers and managed care organizations (MCOs), including health fairs, on-site and at-home testing, vaccinations, and health screenings. It serves pharmaceutical, biotechnology, medical device, and diagnostics companies; and MCOs, employer plans, other health insurance providers, governmental agencies, physicians and other healthcare providers, hospitals and health systems, employers, patients and consumers, contract research organizations, crop protection and chemical companies, academic institutions, independent clinical laboratories, and retailers.
Company Leadership
CC
BC
Founded in 1986, Solis Mammography is an independent provider of mammography and breast health services in the country. Their services include Screening, Diagnostics, Breast Ultrasound, Breast Biopsy, and Bone Density. The company is headquartered in Addison, Texas.
Company Leadership
JJ
Australian Clinical Labs provides a comprehensive range of pathology services, including specialized testing for various health conditions such as cardiac, respiratory, and genetic testing. Their innovative eResults platform enhances communication between healthcare providers and patients, streamlining the process of accessing and sharing test results. The company serves a diverse clientele, including doctors, patients, and commercial entities, offering services like employee health screening and drug testing. With a commitment to quality and patient care, Australian Clinical Labs aims to empower decision-making that improves health outcomes.
Company Leadership SS
DM
MC
AF
Sonora Quest Laboratories, a joint venture between Banner Health and Quest Diagnostics (NYSE: DGX), is part of an integrated laboratory system serving patients throughout Arizona. Sonora Quest Laboratorie provides clinical laboratory testing including local comprehensive test menu which encompasses routine, molecular, prescription drug monitoring, genetic/genomic, women's health and pathology testing services.
Company Leadership JE
LF
SV
Frequently Asked Questions Regarding OPKO Health Top Executives and Leadership Team
